Cargando…

Coverage and diagnostic yield of Whole Exome Sequencing for the Evaluation of Cases with Dilated and Hypertrophic Cardiomyopathy

Targeted next generation sequencing of gene panels has become a popular tool for the genetic diagnosis of hypertrophic (HCM) and dilated cardiomyopathy (DCM). However, it is uncertain whether the use of Whole Exome Sequencing (WES) represents a more effective approach for diagnosis of cases with HCM...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mak, Timothy Shin Heng, Lee, Yee-Ki, Tang, Clara S., Hai, JoJo S. H., Ran, Xinru, Sham, Pak-Chung, Tse, Hung-Fat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6052112/ https://www.ncbi.nlm.nih.gov/pubmed/30022097 http://dx.doi.org/10.1038/s41598-018-29263-3

Ejemplares similares

Diagnostic Yield of Whole Exome Sequencing in Pediatric Dilated Cardiomyopathy
por: Long, Pamela A., et al.
Publicado: (2017)

Whole-Exome Sequencing Reveals Mutational Signature of Hypertrophic Cardiomyopathy
por: Wang, Xi-Qin, et al.
Publicado: (2023)

Prospective Evaluation of the Utility of Whole Exome Sequencing in Dilated Cardiomyopathy
por: Ramchand, Jay, et al.
Publicado: (2020)

Hearing Profile in Patients with Dilated and Hypertrophic Cardiomyopathies
por: El-Zarea, Gehan Abd El-Rahman, et al.
Publicado: (2016)

MicroRNAs in Hypertrophic, Arrhythmogenic and Dilated Cardiomyopathy
por: Chiti, Enrica, et al.
Publicado: (2021)

Hypertrophic, Dilated, and Arrhythmogenic Cardiomyopathy: Where Are We?
por: El Hadi, Hamza, et al.
Publicado: (2023)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Targeted exome analysis of Russian patients with hypertrophic cardiomyopathy
por: Filatova, Elena V., et al.
Publicado: (2021)

Potential digenic inheritance of familial hypertrophic cardiomyopathy identified by whole‐exome sequencing
por: Ren, Ming‐Bao, et al.
Publicado: (2020)

Genetic variations of β-MYH7 in hypertrophic cardiomyopathy and dilated cardiomyopathy
por: Tanjore, Reena, et al.
Publicado: (2010)

Genomic Context Differs Between Human Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy
por: Puckelwartz, Megan J., et al.
Publicado: (2021)

Whole-Exome Sequencing Revealed New Candidate Genes for Human Dilated Cardiomyopathy
por: D’Agostino, Ylenia, et al.
Publicado: (2022)

Investigation of Pathogenic Genes in Chinese sporadic Hypertrophic Cardiomyopathy Patients by Whole Exome Sequencing
por: Xu, Jing, et al.
Publicado: (2015)

Clinical utility of genetic tests for inherited hypertrophic and dilated cardiomyopathies
por: Colombo, Maria Giovanna, et al.
Publicado: (2008)

Reversible transition from a hypertrophic to a dilated cardiomyopathy
por: Spillmann, Frank, et al.
Publicado: (2015)

Mitochondrial Cardiomyopathy Presenting as Dilated Phase of Hypertrophic Cardiomyopathy Diagnosed with Histological and Genetic Analyses
por: Kuno, Toshiki, et al.
Publicado: (2017)

Risk stratification in cardiomyopathies (dilated, hypertrophic, and arrhythmogenic cardiomyopathy) by cardiac magnetic resonance imaging
por: Guglielmo, Marco, et al.
Publicado: (2021)

Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy
por: Campbell, Nzali, et al.
Publicado: (2013)

“Burnt out” dilated hypertrophic cardiomyopathy causing acute LVAD thrombosis
por: Sivathasan, Cumaraswamy, et al.
Publicado: (2015)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells
por: Lee, Yee‐Ki, et al.
Publicado: (2017)

Whole exome sequencing identifies a novel EMD mutation in a Chinese family with dilated cardiomyopathy
por: Zhang, Mingqiu, et al.
Publicado: (2014)

Homozygous truncating mutation in NRAP gene identified by whole exome sequencing in a patient with dilated cardiomyopathy
por: Truszkowska, Grażyna T., et al.
Publicado: (2017)

Whole exome sequencing identifies a KCNJ12 mutation as a cause of familial dilated cardiomyopathy
por: Yuan, Hai-Xin, et al.
Publicado: (2017)

Genetic characterization of dilated cardiomyopathy patients undergoing heart transplantation in the Chinese population by whole-exome sequencing
por: Lian, Hong, et al.
Publicado: (2023)

The necessity for full ventricular coverage with noncontrast T1 mapping in hypertrophic cardiomyopathy
por: Rowin, Ethan, et al.
Publicado: (2013)

Adverse events in families with hypertrophic or dilated cardiomyopathy and mutations in the MYBPC3 gene
por: Ehlermann, Philipp, et al.
Publicado: (2008)

Myocardial fibrosis is not associated with reduced quality of life in patients with dilated or hypertrophic cardiomyopathy
por: Khan, Razi, et al.
Publicado: (2011)

Genetic Test for Dilated and Hypertrophic Cardiomyopathies: Useful or Less Than Useful for Patients?
por: Pastore, F, et al.
Publicado: (2013)

Noncompaction in Healthy Subjects, Dilated and Hypertrophic Cardiomyopathy, and Neuromuscular Disorders Is the Same Entity
por: Stollberger, Claudia, et al.
Publicado: (2015)

Familial risk of dilated and hypertrophic cardiomyopathy: a national family study in Sweden
por: Ricci, Fabrizio, et al.
Publicado: (2022)

Hypertrophic cardiomyopathy is associated with dilated sinus of Valsalva: A case-control study
por: Yoon, Ji Ae, et al.
Publicado: (2023)

Impact of Angiotensin I Converting Enzyme Insertion/Deletion Polymorphisms on Dilated Cardiomyopathy and Hypertrophic Cardiomyopathy Risk
por: Yang, Jianmin, et al.
Publicado: (2013)

Not Only Diagnostic Yield: Whole-Exome Sequencing in Infantile Cardiomyopathies Impacts on Clinical and Family Management
por: Pezzoli, Laura, et al.
Publicado: (2021)

The diagnostic yield of intellectual disability: combined whole genome low-coverage sequencing and medical exome sequencing
por: Wang, Jun, et al.
Publicado: (2020)

Whole-Exome Sequencing Identifies Homozygote Nonsense Variants in LMOD2 Gene Causing Infantile Dilated Cardiomyopathy
por: Sono, Reiri, et al.
Publicado: (2023)

High-sensitivity troponin I and B-type natriuretic peptide biomarkers for prediction of cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
por: Wong, Yuen-Kwun, et al.
Publicado: (2019)

Case Report: Whole Exome Sequencing Identifies Compound Heterozygous Variants in TSFM Gene Causing Juvenile Hypertrophic Cardiomyopathy
por: Yang, Jamie O., et al.
Publicado: (2022)

Predictive value of visit-to-visit blood pressure variability for cardiovascular events in patients with coronary artery disease with and without diabetes mellitus
por: Wong, Yuen-Kwun, et al.
Publicado: (2021)

Potential value of T1 mapping in cardiac MR assessment of hypertrophic cardiomyopathy and dilated cardiomyopathy patients: preliminary results
por: Jacquier, Alexis, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_srsln85bl80ulf0so2oa6hoh8n